The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer
Official Title: A Multi-centre Real-world Non-interventional Observational Study to Evaluate Effectiveness of Sublobar Dissection in the Chinese Patients With Non-small Cell Lung Cancer
Study ID: NCT03427567
Brief Summary: A study to evaluate effectiveness of sublobar dissection in patients with non-small cell lung cancer
Detailed Description: This is a multi-centre real-world non-interventional observational study. The study data on patient demographic/tumor biological characteristics and clinical treatments were retrospectively collected to evaluate effectiveness of sublobar dissection in the Chinese patients with non-small cell lung cancer who received sublobar dissection.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
China-Japan Friendship Hospital, Beijing, Beijing, China
China PLA General Hospital, Beijing, Beijing, China
Henan cancer hospital, Zhengzhou, Henan, China
Tongji Hospital Affiliated to Huazhong Technology Hospital, Wuhan, Hubei, China
Jiangsu cancer hospital, Nanjing, Jiangsu, China
Xi'an Tangdu Hospital, Xi'an, Shaanxi, China
Shanghai Chest Hospital, Shanghai, Shanghai, China
Huaxi Hospital Affiliated to Sichuan University, Chengdu, Sichuan, China
Tianjin Chest Hospital, Tianjin, Tianjin, China
First Hospital Affiliated to Zhejiang University, Hangzhou, Zhejiang, China
Name: Xiangning Fu, PhD
Affiliation: Tongji Hospital Affiliated to Tongji Medical College Huazhong Technology University
Role: PRINCIPAL_INVESTIGATOR